Skip to content

Lipoproteins and Cardiovascular Health

Most cited papers

  1. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry · 1972 · 32,392 citations
  2. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA · 1993 · 27,955 citations
  3. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet · 2004 · 12,388 citations
  4. Diagnosis and Management of the Metabolic SyndromeCirculation · 2005 · 12,143 citations
  5. Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation · 1998 · 9,658 citations
  6. Enzymatic Determination of Total Serum CholesterolClinical Chemistry · 1974 · 9,170 citations
  7. THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation · 1955 · 8,755 citations
  8. General Cardiovascular Risk Profile for Use in Primary CareCirculation · 2008 · 7,745 citations
  9. Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine · 1995 · 7,689 citations
  10. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine · 1996 · 7,419 citations
  11. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation · 2004 · 6,868 citations
  12. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine · 2008 · 6,784 citations
  13. Prevalence of the Metabolic Syndrome Among US AdultsJAMA · 2002 · 6,739 citations
  14. Markers of Inflammation and Cardiovascular DiseaseCirculation · 2003 · 6,553 citations
  15. Beyond CholesterolNew England Journal of Medicine · 1989 · 6,453 citations
  16. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation · 2019 · 6,429 citations
  17. Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine · 2017 · 6,357 citations
  18. Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA · 1998 · 6,205 citations
  19. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine · 2000 · 5,911 citations
  20. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine · 1997 · 5,493 citations
  21. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal · 2003 · 5,367 citations
  22. Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine · 1998 · 5,267 citations
  23. Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA · 1998 · 5,228 citations
  24. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine · 2004 · 4,966 citations
  25. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation · 2019 · 4,613 citations
  26. Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine · 2015 · 4,600 citations
  27. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEuropean Heart Journal · 2017 · 4,216 citations
  28. Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNew England Journal of Medicine · 2018 · 3,463 citations
  29. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ · 2002 · 1,951 citations
  30. Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA · 1997 · 1,816 citations
  31. Trans Fatty Acids and Cardiovascular DiseaseNew England Journal of Medicine · 2006 · 1,804 citations
  32. Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine · 1997 · 1,754 citations
  33. Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine · 2006 · 1,740 citations
  34. A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US PhysiciansJAMA · 1992 · 1,695 citations
  35. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 1,485 citations
  36. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart AssociationCirculation · 2017 · 1,483 citations
  37. Homocysteine Lowering and Cardiovascular Events after Acute Myocardial InfarctionNew England Journal of Medicine · 2006 · 1,452 citations
  38. Effect of Dietary trans Fatty Acids on High-Density and Low-Density Lipoprotein Cholesterol Levels in Healthy SubjectsNew England Journal of Medicine · 1990 · 1,433 citations
  39. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.Journal of Lipid Research · 1985 · 1,353 citations
  40. Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLoS Medicine · 2010 · 1,249 citations
  41. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA · 2020 · 1,083 citations
  42. Total Plasma Homocysteine and Cardiovascular Risk ProfileJAMA · 1995 · 1,077 citations
  43. Effect of Dietary Stearic Acid on Plasma Cholesterol and Lipoprotein LevelsNew England Journal of Medicine · 1988 · 913 citations
  44. Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine · 1985 · 848 citations

Metadata from OpenAlex (CC0).